NANOSPECTRA BIOSCIENCES
Nanospectra Biosciences is a medical device company, engages in developing and commercializing particle-based therapies for the selective and precise thermal destruction of solid tumors. The company provides AuroLase Therapy, a medical device that is applicable to the ablation of various solid tumors. It also offers research-use-only nanoparticles with specific optical characteristics. Nanospectra Biosciences was founded in 2002 and is based in Houston, Texas.
NANOSPECTRA BIOSCIENCES
Industry:
Biotechnology Health Care Life Science Pharmaceutical
Founded:
2002-01-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.nanospectra.com
Total Employee:
1+
Status:
Active
Contact:
7134409349
Email Addresses:
[email protected]
Total Funding:
10.59 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail GoDaddy DNS Google Maps API GoDaddy GoDaddy Email
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Sirtex Medical
Sirtex Medical investment in Series B - Nanospectra Biosciences
Official Site Inspections
http://www.nanospectra.com
- Host name: 16.57.180.107.host.secureserver.net
- IP address: 107.180.57.16
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Nanospectra Biosciences"
Nanospectra | Leveraging Nanoshells in the First True Focal Therapy
Nanospectra Biosciences is a medical device company pioneering a patient-centric use of nanomedicine for selective thermal ablation. Nanospectra’s proprietary ultra-focal technology …See details»
Company | Nanospectra
Nanospectra Biosciences is a medical device company pioneering a patient-centric use of nanomedicine for selective thermal ablation. The company is bringing a new technology model …See details»
Nanospectra Biosciences - Crunchbase Company …
Nanospectra Biosciences develops particle-based therapies for the selective and precise thermal destruction of solid tumors. View contacts for Nanospectra Biosciences to access new leads and connect with decision-makers.See details»
Nanospectra Company Profile 2024: Valuation, Funding …
Developer of tissue ablation therapies designed to maximize treatment efficacy while minimizing side effects.See details»
Nanospectra Biosciences, Inc. - LinkedIn
Nanospectra Biosciences is a medical device company pioneering a patient-centric use of nanomedicine for selective thermal ablation.See details»
Technology - Nanospectra
Nanospectra’s proprietary technology platform is demonstrated to be safe and effective in initial clinical trials and viable for multiple applications including solid tumors, tissue and drug delivery.See details»
Nanospectra Biosciences, Inc. | Scientist.com
Nanospectra Biosciences is a private company founded in 2002. Nanospectra has an exclusive license from Rice University to eleven issued US patents related to nanoshells and related …See details»
Nanospectra Biosciences Company Profile - Craft
Nanospectra Biosciences is a company specializing in nanomedicine for selective thermal ablation. It offers AuroLase ultra-focal therapy device to treat solid tumors without damaging …See details»
Nanospectra Biosciences - Funding, Financials, Valuation & Investors
Nanospectra Biosciences develops particle-based therapies for the selective and precise thermal destruction of solid tumors.See details»
CancerFighting Nanoparticles - ASME
Mar 13, 2013 · In 2010, Berlin, Germany-based MagForce Nanotechnologies was the first company worldwide to receive European regulatory approval for its procedure using nanoparticles, small bits of iron oxide suspended in a liquid. …See details»
Nanospectra Biosciences Raises First Tranche of Series B-1 …
Sep 8, 2020 · Nanospectra Biosciences is a privately-held medical device company, pioneering the patient-centric use of nanomedicine for selective thermal ablation. AuroLase ®, the …See details»
Nanospectra Biosciences Provides Corporate Update
Mar 28, 2018 · Nanospectra Biosciences is a privately-held medical device company, pioneering the patient-centric use of nanomedicine for selective thermal ablation. AuroLase®, the …See details»
Nanospectra Biosciences Announces Enrollment Completion of …
HOUSTON, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Nanospectra Biosciences, Inc., a medical device company pioneering a novel use of nanomedicine for selective photothermal ablation, …See details»
Nanoparticle therapy offers new hope for prostate cancer patients
Oct 17, 2024 · This new cancer treatment is being commercialized by Nanospectra Biosciences, Inc., a company co-founded by Dean West. A Multi-Institutional Study of Magnetic …See details»
First Results for Nanosphere Focal Therapy in Prostate Cancer
Aug 28, 2019 · His team has just reported early results from a small trial of focal therapy for discrete lesions in the prostate using gold-silica nanoshell (GSN)–directed laser technology …See details»
Movers & Shakers | MRS Bulletin - Springer
Jul 27, 2023 · She co-founded two companies: Nanospectra Biosciences, Inc., for the development of localized cancer therapeutics, and Syzygy Plasmonics, for the development of …See details»
Press Releases - Nanospectra
HOUSTON, TX – August 27, 2019 – Nanospectra Biosciences, Inc., a medical device company pioneering a novel use of nanomedicine for selective thermal tissue ablation, announced today …See details»
Nanoparticle Therapy Offers New Hope for Prostate Cancer Patients
Oct 16, 2024 · This new cancer treatment is being commercialized by Nanospectra Biosciences, Inc., a company co-founded by Dean West. " A Multi-Institutional Study of Magnetic …See details»
Nanospectra’s Nanoparticle Light Therapy for Prostate Cancer …
Aug 27, 2019 · By making variations in the thickness of the gold shell, Halas can “tune” the nanoshells to interact with specific light wavelengths. In 2000, Halas and Jennifer West, a …See details»
Media - Nanospectra
Oct 11, 2019 · Select Page. PRESS RELEASES ...See details»